
Utah Gathers at BIO International 2024 in San Diego
June 6, 2024
BioUtah and its Utah consortium made their mark this week at the BIO International Conference, hosting a Utah Pavillion to promote the state’s fast-growing life sciences industry. The conference, held in San Diego, CA. drew appproximately 19,000 attendees. The Utah delegation included BioUtah, Utah companies, the Governor’s Office of Economic Development, the Unversity of Utah’s Technology Licensing Office, EDCUtah and the Utah World Trade Center. The Pavillion provided an exceptional opportunity to showcase Utah’s dynamic biotech community to a large audience from across the nation and worldwide. “The conference provided a venue to raise the profile of Utah’s growing pharma sector and tell our story,” said Kelvyn Cullimore, president and CEO of BioUtah. The sessions were enlightening and we were able to make connections that can benefit Utah companies and our industry as a whole.” BioUtah also engaged with the UK contingent at the conference, where conversations continued around executing on the Utah-UK Memorandum of Understaning (MOU) signed by Gov. Cox last year. The MOU specifically includes life sciences.
Recent News
- Collaboration with Quest Diagnostics to expand kidneyintelX.dkd TM testing in the United States
- Utah Business Innovation Awards Summit Recap
- Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy
- Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
- Rep. Celeste Maloy Tours BIOS, Neurotech Innovation
- U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam for Pediatric Patients with Tourette Syndrome






























